Vienna, Austria

Manfred Reiter

USPTO Granted Patents = 71 


 

Average Co-Inventor Count = 3.9

ph-index = 14

Forward Citations = 634(Granted Patents)

Forward Citations (Not Self Cited) = 478(Oct 12, 2025)


Inventors with similar research interests:


Company Filing History:


Years Active: 1993-2023

Loading Chart...
Loading Chart...
Loading Chart...
71 patents (USPTO):

Title: Manfred Reiter: A Leading Innovator in Biopharmaceutical Technologies

Introduction: Manfred Reiter, based in Vienna, Austria, is a prolific inventor known for his significant contributions to the biopharmaceutical field. With an impressive portfolio of 71 patents, his work has pushed the boundaries of innovation, particularly in the production and analysis of recombinant proteins.

Latest Patents: Among his latest patents, Manfred has developed a "Method of producing recombinant high molecular weight vWF in cell culture," which focuses on optimizing cell culture conditions to produce high multimeric von Willebrand factor (vWF) and ADAMTS13 with enhanced specific activity. This innovative method involves using a specific cell culture medium, characterized by increased copper concentration and low ammonium levels, to achieve better results in cell cultivation and protein expression. Another notable patent is the "Method of predicting a performance characteristic of a plant or yeast hydrolysate and its use." This patent describes a process using 2D fluorescence spectroscopy to predict important manufacturing parameters, allowing for refined decision-making in production processes of recombinant proteins.

Career Highlights: Manfred Reiter’s professional journey includes critical roles at prominent companies such as Baxalta GmbH and Baxter Healthcare SA, where he contributed to groundbreaking advancements in biopharmaceutical manufacturing. His extensive experience in the industry has equipped him with the expertise to tackle complex challenges in the development of recombinant proteins and related technologies.

Collaborations: Throughout his career, Manfred has had the opportunity to work alongside esteemed colleagues, including Wolfgang Mundt and Leopold Grillberger. These collaborations have fostered a vibrant exchange of ideas and innovations, further enhancing the quality and impact of their work in the biopharmaceutical sector.

Conclusion: Manfred Reiter stands out as a leading figure in the innovation landscape of biopharmaceuticals. His numerous patents and collaborations demonstrate his commitment to advancing technology in this critical field. As the industry continues to evolve, Reiter's contributions will undoubtedly leave a lasting impact on the capabilities and effectiveness of biopharmaceutical manufacturing methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…